Valuation of Canada's cannabis stocks
By ATB Investment Management Inc. 11 March 2019 4 min read
Smoking up on valuations
Canadian Cannabis Stocks
Canada is due to fully legalize marijuana in the second half of 2018, the first G7 country to do so on a national basis. In anticipation of this, many Canadian companies are investing in order to fulfill the demand. Many unknowns remain. For example, the provincial regulations that will govern marijuana distribution will differ across provinces, with some provinces proposing distribution only through government-owned stores, while others are expected to allow distribution through privately operated retail outlets. However, the marijuana market in Canada will ultimately behave like every other commodity, with supply, demand, and pricing all having an impact.
The number of publicly-traded Canadian companies associated with marijuana production has grown dramatically and early investors experienced outsized returns, leading to potential new investors clamoring to buy before legalization. This begs the question, does investment in this segment still make sense?
Size of the Marijuana Industry
Statistics Canada1 estimated retail prices between $7.14 and $8.84 per gram, and most estimates mention prices no higher than $10 per gram, inclusive of both recreational and medical grade marijuana. Therefore we anticipate average retail prices including taxes to not exceed $10 per gram.
Statistics Canada also estimated Canadian usage of 700 tonnes per year in a 2015 report, which at $10 per gram equals $7 billion of annual sales.
The state of Colorado, having legalized marijuana several years ago, is a source of reasonable estimates. The Colorado Department of Revenue2 reported recreational and medical cannabis sales of approximately $1.5 billion US in 2017. Adjusted for some marijuana tourism, this translates into roughly $270 US per person. At $340 Canadian per person at current exchange rates, and applied across a population of 35 million Canadians, this equals to about $12 billion of total annual Canadian sales. For comparison, per person annual alcohol consumption3 in Canada was about $740 in 2015-2016 and annual tobacco expenditure4 was roughly $670.
Our total industry revenue estimates of $7-12 billion include retail/distribution markups and taxes. Canadian cannabis producers would likely capture half of that, to arrive at total revenue estimates of $3.5-6 billion. Another way to look at this, is if marijuana sells at $10 per gram, producers receive $5 per gram, and the other $5 per gram goes to retail markups and taxes.
Market Value of Cannabis
The common shares of the 20 largest Canadian marijuana-specific stocks, as held within the Horizons Marijuana Life Sciences exchange-traded fund5, had an aggregate stock market value of $25 billion Canadian at the end of January. Because these companies carried virtually no debt, their “enterprise value” was essentially the same. If we divide this amount by their estimated annual revenue of $3.5-6 billion, the resulting ratio indicates that investors currently value this sector’s stocks at between 4.2 and 7.1 times every dollar of revenue. How does this compare with valuations of other similar industries?
The stocks of large tobacco6 companies are currently valued an average 4.8 times their annual revenues (“4.8X”), pharmaceutical6 companies average about 4X, and alcohol6 companies average about 3X. Tobacco companies are generally thought to have the highest valuation because their profit margins are higher than those of pharmaceutical companies, which in turn are higher than those of alcohol distillers. Because cannabis producers are essentially more agricultural than industrial or technological in nature, and because the industry’s barriers to entry are very minimal (i.e. no more difficult than establishing a greenhouse), their profit margins will likely lie closer to the lower end of this spectrum.
Canadian cannabis producer valuations of 4.2-7.1X are already higher than the 3-4.8X range of similar industries. Along with lower expected profitability, this strongly suggests that the Canadian cannabis producer market is already somewhat overvalued.
Other impacts to consider
Since legalization has not yet occurred, many unknown factors can further affect this market. To list just a few:
- Legal age - a higher legal age will reduce demand because primary users are younger
- Minimum pricing - if government sets a minimum price higher than the illicit market, commercial demand will be reduced
- Self-supply - if individuals can legally grow their supply at home, this will reduce demand for commercially-produced cannabis
One factor often mentioned to support current valuations is the first-mover advantage Canadian producers might have, should other countries eventually legalize. However, the minimal barriers to establishing marijuana production in Canada are no different elsewhere, and we see no reason other countries will be beholden to Canadian-produced marijuana.
Closing thoughts - it's too early to tell...
Only hindsight is 20/20, and nobody knows with certainty what the marijuana market will look like in ten years. Perhaps some Canadian producers will fend off new entrants in Canada and elsewhere, and capture a meaningful slice of the global market. Looking at only Canadian demand, however, current stock valuations make the Canadian marijuana industry seem somewhat overpriced and risky for new investors.
Source:1Statistics Canada - Economic Insights - Experimental Estimates of Cannabis Consumption in Canada, 1960 to 2015
2Colorado Department of Revenue - Marijuana sales report
3Statistics Canada - Alcohol consumption
4Statistics Canada - Tobacco usage
5Horizon Exchange Traded Funds - Horizons Marijuana Life Sciences Index ETF
ATB Wealth® (a registered trade name) consists of a range of financial services provided by ATB Financial and certain of its subsidiaries. ATB Investment Management Inc., and ATB Securities Inc. are individually licensed users of ATB Wealth. ATB Securities Inc. is a member of the Canadian Investor Protection Fund and the Canadian Investment Regulatory Organization.
The information contained herein has been compiled or arrived at from sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy or completeness, and ATB Wealth (this includes all the above legal entities) does not accept any liability or responsibility whatsoever for any loss arising from any use of this document or its contents. This information is subject to change and ATB Wealth does not undertake to provide updated information should a change occur. This document may not be reproduced in whole or in part, or referred to in any manner whatsoever, nor may the information, opinions and conclusions contained in it be referred to without the prior consent of the appropriate legal entity using ATB Wealth. This document is being provided for information purposes only and is not intended to replace or serve as a substitute for professional advice, nor as an offer to sell or a solicitation of an offer to buy any investment. Professional legal and tax advice should always be obtained when dealing with legal and taxation issues as each individual’s situation is different.